GGrantIndex
← Leaderboards

Kenneth L. Roland

Celldex Therapeutics, Inc.

$1,398,998
Attributed
$1,398,998
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $231.8K · FY200516
$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16

Funding mix

By agency

NIH$1,398,998 · 4

By mechanism

R21$1,268,188 · 3
R43$130,810 · 1

Top collaborators

No co-investigators on record.

Most similar at Celldex Therapeutics, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Heterophile Antigens

Research focus

Heterophile AntigensAnimal ModelLifeBacteriaSalmonella TyphimuriumSalmonella TyphiSalmonellaVaccinesImmune ResponseImmunogenicityPathogenBaseAttenuatedOralRecombinantsCostSalmonella VaccinesTissuesLegal PatentInfectionResearch StudyEnteric PathogenEnvironmentIntestines

Grant awards (7)